Delivery Order SPE2DB24D2012-SPE2DB25FBVVK

Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $2,265.90 and a period of performance through April 17, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a total ceiling value of $1,014.65 and a period of performance through April 23, 2025. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication, with a ceiling value of $9,744.97 and a completion date of November 29, 2022. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,598.00, is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has a firm fixed-price pricing type and a period of performance through May 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...
This is a delivery order awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for HUMIRA PEN 40 MG/0.8 MLS, a specialty medication, with a ceiling value of $2,770.74. The contract has an ultimate completion date of July 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialized medication, with a ceiling value of $2,648.17 and a period of performance through January 31, 2025. The contract is a Firm Fixed Price type with no set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,311.92, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication. The contract has a firm fixed price pricing type and a completion date of February 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA PEN 40 MG/0.8 MLS. The contract has a ceiling value of $1,926.89 and a completion date of March 7, 2023. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,620.65, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a completion date of April 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a medication used to treat various medical conditions. The contract has a firm fixed price, a ceiling value of $1,549.21, and a period of performance through April 17, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen...
  • SPE2DB24D2012
    Indefinite Delivery Contract
  • SPE2DB24D2012-SPE2DB25FBVVK
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 80 MG/0.8 MLS, a prescription medication, with a ceiling value of $8,951.41 and a performance period through April 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely one of many made under the larger IDC to support federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/21/25, 7:42 PM